

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular response to interferon-alpha (GO:0035457) | 6.67599284 |
| 2 | positive regulation of interferon-alpha production (GO:0032727) | 6.42804347 |
| 3 | * cellular response to type I interferon (GO:0071357) | 6.07029832 |
| 4 | * type I interferon signaling pathway (GO:0060337) | 6.07029832 |
| 5 | regulation of interferon-alpha production (GO:0032647) | 6.05590694 |
| 6 | * response to type I interferon (GO:0034340) | 6.01510601 |
| 7 | response to interferon-alpha (GO:0035455) | 5.95576192 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.81122294 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.81122294 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 5.81122294 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 5.81122294 |
| 12 | modulation by symbiont of host defense response (GO:0052031) | 5.81122294 |
| 13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.81122294 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.75345268 |
| 15 | response to peptidoglycan (GO:0032494) | 5.20168866 |
| 16 | cellular response to interferon-beta (GO:0035458) | 5.02658808 |
| 17 | * negative regulation of viral genome replication (GO:0045071) | 4.69005825 |
| 18 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.61913723 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 4.59828629 |
| 20 | positive regulation of interferon-beta production (GO:0032728) | 4.57170749 |
| 21 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.52216803 |
| 22 | response to host immune response (GO:0052572) | 4.52216803 |
| 23 | cellular response to virus (GO:0098586) | 4.48968093 |
| 24 | response to interferon-beta (GO:0035456) | 4.45399168 |
| 25 | immunoglobulin mediated immune response (GO:0016064) | 4.42153742 |
| 26 | regulation of RIG-I signaling pathway (GO:0039535) | 4.40611831 |
| 27 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.35480201 |
| 28 | positive regulation of type 2 immune response (GO:0002830) | 4.28621203 |
| 29 | * regulation of viral genome replication (GO:0045069) | 4.26967154 |
| 30 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.25099975 |
| 31 | negative regulation of interleukin-12 production (GO:0032695) | 4.23840656 |
| 32 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.17630630 |
| 33 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.17606630 |
| 34 | T cell migration (GO:0072678) | 4.13522603 |
| 35 | regulation of type 2 immune response (GO:0002828) | 4.10441675 |
| 36 | natural killer cell activation involved in immune response (GO:0002323) | 4.07548226 |
| 37 | regulation of MHC class I biosynthetic process (GO:0045343) | 4.02219959 |
| 38 | positive regulation of cAMP-mediated signaling (GO:0043950) | 4.01756315 |
| 39 | macrophage activation involved in immune response (GO:0002281) | 4.00831187 |
| 40 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.00396051 |
| 41 | response to host defenses (GO:0052200) | 3.97165600 |
| 42 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.97165600 |
| 43 | response to host (GO:0075136) | 3.97165600 |
| 44 | negative regulation of type 2 immune response (GO:0002829) | 3.92598624 |
| 45 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.91359195 |
| 46 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.87153523 |
| 47 | lymphocyte chemotaxis (GO:0048247) | 3.84764309 |
| 48 | regulation of chemokine biosynthetic process (GO:0045073) | 3.80916308 |
| 49 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.78672308 |
| 50 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.78672308 |
| 51 | negative regulation of cell killing (GO:0031342) | 3.78002199 |
| 52 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.78002199 |
| 53 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.77821637 |
| 54 | natural killer cell mediated immunity (GO:0002228) | 3.77821637 |
| 55 | eosinophil chemotaxis (GO:0048245) | 3.76801259 |
| 56 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.74464439 |
| 57 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.72999942 |
| 58 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.72155186 |
| 59 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.71273787 |
| 60 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.67322681 |
| 61 | negative regulation of T cell mediated immunity (GO:0002710) | 3.65039697 |
| 62 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.61929741 |
| 63 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.60774058 |
| 64 | respiratory burst (GO:0045730) | 3.58103477 |
| 65 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.57093253 |
| 66 | microglial cell activation (GO:0001774) | 3.57014696 |
| 67 | defense response to protozoan (GO:0042832) | 3.54759070 |
| 68 | granulocyte activation (GO:0036230) | 3.51921989 |
| 69 | positive regulation of T cell cytokine production (GO:0002726) | 3.48957374 |
| 70 | positive regulation of interleukin-12 production (GO:0032735) | 3.47639687 |
| 71 | * defense response to virus (GO:0051607) | 3.47220633 |
| 72 | positive regulation of interleukin-17 production (GO:0032740) | 3.45498097 |
| 73 | regulation of activation of Janus kinase activity (GO:0010533) | 3.45246087 |
| 74 | cellular response to interferon-gamma (GO:0071346) | 3.41902173 |
| 75 | detection of other organism (GO:0098543) | 3.40637341 |
| 76 | superoxide anion generation (GO:0042554) | 3.40477384 |
| 77 | regulation of mononuclear cell migration (GO:0071675) | 3.39833055 |
| 78 | positive regulation of lymphocyte migration (GO:2000403) | 3.38448094 |
| 79 | B cell mediated immunity (GO:0019724) | 3.38432342 |
| 80 | negative regulation of type I interferon production (GO:0032480) | 3.37366439 |
| 81 | monocyte chemotaxis (GO:0002548) | 3.33769317 |
| 82 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.33445749 |
| 83 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.32421089 |
| 84 | eosinophil migration (GO:0072677) | 3.29933909 |
| 85 | regulation of interleukin-17 production (GO:0032660) | 3.29065518 |
| 86 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 3.27118323 |
| 87 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 3.27118323 |
| 88 | regulation of interferon-beta production (GO:0032648) | 3.26736495 |
| 89 | reactive oxygen species biosynthetic process (GO:1903409) | 3.25030548 |
| 90 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.24986313 |
| 91 | neutrophil activation (GO:0042119) | 3.24673176 |
| 92 | response to muramyl dipeptide (GO:0032495) | 3.22151991 |
| 93 | detection of external biotic stimulus (GO:0098581) | 3.21649235 |
| 94 | * cellular response to exogenous dsRNA (GO:0071360) | 3.21037069 |
| 95 | detection of bacterium (GO:0016045) | 3.18772541 |
| 96 | T-helper 1 type immune response (GO:0042088) | 3.16762892 |
| 97 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.15550726 |
| 98 | negative regulation of interleukin-17 production (GO:0032700) | 3.11930265 |
| 99 | regulation of toll-like receptor signaling pathway (GO:0034121) | 3.11153508 |
| 100 | myeloid cell activation involved in immune response (GO:0002275) | 3.10853399 |
| 101 | positive regulation of defense response to virus by host (GO:0002230) | 3.09439307 |
| 102 | positive regulation of heat generation (GO:0031652) | 3.08901523 |
| 103 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.08502396 |
| 104 | detection of molecule of bacterial origin (GO:0032490) | 3.08249402 |
| 105 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.07848849 |
| 106 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.06528672 |
| 107 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.05255868 |
| 108 | response to interferon-gamma (GO:0034341) | 3.04295828 |
| 109 | * response to exogenous dsRNA (GO:0043330) | 3.04154992 |
| 110 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.02119485 |
| 111 | positive regulation of response to biotic stimulus (GO:0002833) | 2.99514673 |
| 112 | regulation of fever generation (GO:0031620) | 2.98116746 |
| 113 | response to protozoan (GO:0001562) | 2.97916938 |
| 114 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.96946218 |
| 115 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.96755569 |
| 116 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.96338929 |
| 117 | NIK/NF-kappaB signaling (GO:0038061) | 2.94925977 |
| 118 | * negative regulation of viral process (GO:0048525) | 2.94331380 |
| 119 | cellular response to zinc ion (GO:0071294) | 2.93835702 |
| 120 | positive regulation of antigen processing and presentation (GO:0002579) | 2.93446752 |
| 121 | interferon-gamma secretion (GO:0072643) | 2.92538591 |
| 122 | myeloid dendritic cell differentiation (GO:0043011) | 2.92457870 |
| 123 | germinal center formation (GO:0002467) | 2.91865987 |
| 124 | positive regulation of chemokine production (GO:0032722) | 2.91109019 |
| 125 | regulation of T cell tolerance induction (GO:0002664) | 2.90163925 |
| 126 | regulation of T cell cytokine production (GO:0002724) | 2.90151437 |
| 127 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.89566303 |
| 128 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.88420926 |
| 129 | * response to virus (GO:0009615) | 2.87270137 |
| 130 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.85515564 |
| 131 | macrophage activation (GO:0042116) | 2.82025370 |
| 132 | regulation of response to interferon-gamma (GO:0060330) | 2.77647037 |
| 133 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.75689863 |
| 134 | detection of biotic stimulus (GO:0009595) | 2.75299097 |
| 135 | negative regulation of viral entry into host cell (GO:0046597) | 2.74109920 |
| 136 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.73515824 |
| 137 | regulation of cytokine production involved in immune response (GO:0002718) | 2.71738285 |
| 138 | JAK-STAT cascade (GO:0007259) | 2.71237256 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 9.19914681 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.63235205 |
| 3 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 6.78237045 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.04290493 |
| 5 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.46958809 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.61188827 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.14579585 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.39253754 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.27344683 |
| 10 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.17509021 |
| 11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.99726697 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.94305640 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.80552129 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.64523355 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.38012299 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.36332578 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.32599208 |
| 18 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.32447111 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.04225590 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.54473359 |
| 21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.53368048 |
| 22 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.52127226 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.49118374 |
| 24 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.48188235 |
| 25 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.47612188 |
| 26 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.45058083 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 1.44836794 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.44616771 |
| 29 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.44552916 |
| 30 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.42574911 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.42048601 |
| 32 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38173652 |
| 33 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30869416 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.28618417 |
| 35 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.27384847 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.26231919 |
| 37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.25212311 |
| 38 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.23624940 |
| 39 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.20567082 |
| 40 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.19258043 |
| 41 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18170658 |
| 42 | MAF_26560356_Chip-Seq_TH1_Human | 1.15828985 |
| 43 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.15670234 |
| 44 | GATA3_26560356_Chip-Seq_TH2_Human | 1.15257405 |
| 45 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13545700 |
| 46 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.13117357 |
| 47 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12587558 |
| 48 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.12127341 |
| 49 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11989459 |
| 50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05627692 |
| 51 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04061436 |
| 52 | * MYB_26560356_Chip-Seq_TH1_Human | 1.01900515 |
| 53 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.01141177 |
| 54 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.00834220 |
| 55 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00237335 |
| 56 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96905120 |
| 57 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.96183106 |
| 58 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.95586498 |
| 59 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94498278 |
| 60 | SPI1_23127762_ChIP-Seq_K562_Human | 0.93760671 |
| 61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.93403557 |
| 62 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.93126074 |
| 63 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.93111877 |
| 64 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.92485828 |
| 65 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.92200686 |
| 66 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91065436 |
| 67 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.90830593 |
| 68 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.89819145 |
| 69 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.89819145 |
| 70 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.89706725 |
| 71 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.88246621 |
| 72 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87034261 |
| 73 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.86710601 |
| 74 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86044016 |
| 75 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.85821752 |
| 76 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.82296516 |
| 77 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81864693 |
| 78 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.81787331 |
| 79 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81778258 |
| 80 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.81765423 |
| 81 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81363996 |
| 82 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76511701 |
| 83 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.76019080 |
| 84 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.75437072 |
| 85 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74594583 |
| 86 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73525550 |
| 87 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.73226908 |
| 88 | GATA1_19941826_ChIP-Seq_K562_Human | 0.73092334 |
| 89 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.72846515 |
| 90 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.72801017 |
| 91 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.72435072 |
| 92 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71396423 |
| 93 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71245733 |
| 94 | CJUN_26792858_Chip-Seq_BT549_Human | 0.70959230 |
| 95 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.70526645 |
| 96 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.70100264 |
| 97 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.67548567 |
| 98 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.67430167 |
| 99 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.67256297 |
| 100 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.67200329 |
| 101 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.66894846 |
| 102 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.65897973 |
| 103 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.65520076 |
| 104 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.65201132 |
| 105 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.65166596 |
| 106 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.64236407 |
| 107 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.64059544 |
| 108 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.62880176 |
| 109 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.62346642 |
| 110 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.60104623 |
| 111 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.58250809 |
| 112 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.57403428 |
| 113 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.57099452 |
| 114 | UTX_26944678_Chip-Seq_JUKART_Human | 0.55949347 |
| 115 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.55908797 |
| 116 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.55684387 |
| 117 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.55440589 |
| 118 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.54731134 |
| 119 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.54089272 |
| 120 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.54021284 |
| 121 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.53668072 |
| 122 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.53154891 |
| 123 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.52316850 |
| 124 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.52097159 |
| 125 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.51925883 |
| 126 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.51446205 |
| 127 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.51446205 |
| 128 | MAF_26560356_Chip-Seq_TH2_Human | 0.50451897 |
| 129 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.50427308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009785_altered_susceptibility_to | 4.89296614 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.78448940 |
| 3 | MP0003724_increased_susceptibility_to | 4.32900531 |
| 4 | MP0006082_CNS_inflammation | 4.32358815 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 4.00535916 |
| 6 | MP0003436_decreased_susceptibility_to | 3.72055384 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.50496191 |
| 8 | MP0005025_abnormal_response_to | 3.41879601 |
| 9 | MP0001790_abnormal_immune_system | 3.08196190 |
| 10 | MP0005387_immune_system_phenotype | 3.08196190 |
| 11 | MP0005671_abnormal_response_to | 3.07763126 |
| 12 | MP0004510_myositis | 3.05816950 |
| 13 | MP0002419_abnormal_innate_immunity | 3.01864910 |
| 14 | MP0000685_abnormal_immune_system | 2.93797348 |
| 15 | MP0003303_peritoneal_inflammation | 2.75218238 |
| 16 | MP0002723_abnormal_immune_serum | 2.69961994 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.63348940 |
| 18 | MP0001800_abnormal_humoral_immune | 2.62941555 |
| 19 | MP0009764_decreased_sensitivity_to | 2.45433444 |
| 20 | MP0001533_abnormal_skeleton_physiology | 2.25486450 |
| 21 | MP0001819_abnormal_immune_cell | 2.22816339 |
| 22 | MP0004947_skin_inflammation | 2.15993309 |
| 23 | MP0002420_abnormal_adaptive_immunity | 2.15959302 |
| 24 | MP0002006_tumorigenesis | 2.08191188 |
| 25 | MP0008469_abnormal_protein_level | 1.99129521 |
| 26 | MP0001853_heart_inflammation | 1.98400400 |
| 27 | MP0001845_abnormal_inflammatory_respons | 1.95299168 |
| 28 | MP0005058_abnormal_lysosome_morphology | 1.82377868 |
| 29 | MP0003448_altered_tumor_morphology | 1.81257731 |
| 30 | MP0010155_abnormal_intestine_physiology | 1.77310334 |
| 31 | MP0000343_altered_response_to | 1.75404098 |
| 32 | MP0002877_abnormal_melanocyte_morpholog | 1.74250984 |
| 33 | MP0005464_abnormal_platelet_physiology | 1.67281611 |
| 34 | MP0005451_abnormal_body_composition | 1.65203069 |
| 35 | MP0002405_respiratory_system_inflammati | 1.61602921 |
| 36 | MP0000716_abnormal_immune_system | 1.57516076 |
| 37 | MP0003075_altered_response_to | 1.56998451 |
| 38 | MP0002166_altered_tumor_susceptibility | 1.55873122 |
| 39 | MP0005310_abnormal_salivary_gland | 1.51225113 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.47327277 |
| 41 | MP0002398_abnormal_bone_marrow | 1.42487279 |
| 42 | MP0004782_abnormal_surfactant_physiolog | 1.40579739 |
| 43 | MP0002998_abnormal_bone_remodeling | 1.40091279 |
| 44 | MP0006054_spinal_hemorrhage | 1.38162860 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.32415483 |
| 46 | MP0008004_abnormal_stomach_pH | 1.31139070 |
| 47 | MP0005167_abnormal_blood-brain_barrier | 1.30897867 |
| 48 | MP0002277_abnormal_respiratory_mucosa | 1.30496897 |
| 49 | MP0009278_abnormal_bone_marrow | 1.30005849 |
| 50 | MP0000858_altered_metastatic_potential | 1.28489211 |
| 51 | MP0005166_decreased_susceptibility_to | 1.25386258 |
| 52 | MP0005164_abnormal_response_to | 1.20971476 |
| 53 | MP0003186_abnormal_redox_activity | 1.19903017 |
| 54 | MP0002429_abnormal_blood_cell | 1.19691023 |
| 55 | MP0009763_increased_sensitivity_to | 1.16359520 |
| 56 | MP0009840_abnormal_foam_cell | 1.13863207 |
| 57 | MP0002139_abnormal_hepatobiliary_system | 1.12532851 |
| 58 | MP0000604_amyloidosis | 1.11717902 |
| 59 | MP0005397_hematopoietic_system_phenotyp | 1.10197296 |
| 60 | MP0001545_abnormal_hematopoietic_system | 1.10197296 |
| 61 | MP0005390_skeleton_phenotype | 1.06980103 |
| 62 | MP0003806_abnormal_nucleotide_metabolis | 1.06076270 |
| 63 | MP0003183_abnormal_peptide_metabolism | 1.05979828 |
| 64 | MP0001542_abnormal_bone_strength | 1.05351274 |
| 65 | MP0000689_abnormal_spleen_morphology | 1.04013791 |
| 66 | MP0003172_abnormal_lysosome_physiology | 1.03961477 |
| 67 | MP0002254_reproductive_system_inflammat | 1.03629011 |
| 68 | MP0003763_abnormal_thymus_physiology | 1.00431316 |
| 69 | MP0002722_abnormal_immune_system | 0.99261150 |
| 70 | MP0003690_abnormal_glial_cell | 0.98070678 |
| 71 | MP0003195_calcinosis | 0.96175216 |
| 72 | MP0002933_joint_inflammation | 0.95873188 |
| 73 | MP0004858_abnormal_nervous_system | 0.95743691 |
| 74 | MP0003221_abnormal_cardiomyocyte_apopto | 0.89764554 |
| 75 | MP0010307_abnormal_tumor_latency | 0.87042680 |
| 76 | MP0002138_abnormal_hepatobiliary_system | 0.85739999 |
| 77 | MP0008874_decreased_physiological_sensi | 0.84693217 |
| 78 | MP0003045_fibrosis | 0.83912326 |
| 79 | MP0003453_abnormal_keratinocyte_physiol | 0.82516620 |
| 80 | MP0010386_abnormal_urinary_bladder | 0.80416372 |
| 81 | MP0001851_eye_inflammation | 0.79313730 |
| 82 | MP0003252_abnormal_bile_duct | 0.77530074 |
| 83 | MP0003091_abnormal_cell_migration | 0.76818370 |
| 84 | MP0004808_abnormal_hematopoietic_stem | 0.76253909 |
| 85 | MP0008438_abnormal_cutaneous_collagen | 0.76210839 |
| 86 | MP0003879_abnormal_hair_cell | 0.74930299 |
| 87 | MP0003656_abnormal_erythrocyte_physiolo | 0.74085183 |
| 88 | MP0000249_abnormal_blood_vessel | 0.70814334 |
| 89 | MP0000465_gastrointestinal_hemorrhage | 0.70581277 |
| 90 | MP0003866_abnormal_defecation | 0.69096495 |
| 91 | MP0003705_abnormal_hypodermis_morpholog | 0.67894759 |
| 92 | MP0003300_gastrointestinal_ulcer | 0.67096803 |
| 93 | MP0003136_yellow_coat_color | 0.66377574 |
| 94 | MP0002136_abnormal_kidney_physiology | 0.65665837 |
| 95 | MP0003279_aneurysm | 0.63651623 |
| 96 | MP0002332_abnormal_exercise_endurance | 0.61169172 |
| 97 | MP0003828_pulmonary_edema | 0.58863725 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.57971372 |
| 99 | MP0000372_irregular_coat_pigmentation | 0.57038256 |
| 100 | MP0008260_abnormal_autophagy | 0.55239214 |
| 101 | MP0001958_emphysema | 0.55099299 |
| 102 | MP0003329_amyloid_beta_deposits | 0.54927985 |
| 103 | MP0003795_abnormal_bone_structure | 0.53874643 |
| 104 | MP0002693_abnormal_pancreas_physiology | 0.53573842 |
| 105 | MP0005023_abnormal_wound_healing | 0.53034995 |
| 106 | MP0004883_abnormal_blood_vessel | 0.52346154 |
| 107 | MP0001881_abnormal_mammary_gland | 0.52060067 |
| 108 | MP0002090_abnormal_vision | 0.50195067 |
| 109 | MP0003566_abnormal_cell_adhesion | 0.49985420 |
| 110 | MP0000920_abnormal_myelination | 0.48349221 |
| 111 | MP0001348_abnormal_lacrimal_gland | 0.47272111 |
| 112 | MP0000767_abnormal_smooth_muscle | 0.46517687 |
| 113 | MP0005165_increased_susceptibility_to | 0.46276825 |
| 114 | MP0005319_abnormal_enzyme/_coenzyme | 0.45915463 |
| 115 | MP0001346_abnormal_lacrimal_gland | 0.45571284 |
| 116 | MP0001873_stomach_inflammation | 0.45216535 |
| 117 | MP0002168_other_aberrant_phenotype | 0.44800747 |
| 118 | MP0001663_abnormal_digestive_system | 0.44582032 |
| 119 | MP0001501_abnormal_sleep_pattern | 0.44565617 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 7.01442555 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.48168564 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.18121044 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.82624954 |
| 5 | Increased IgM level (HP:0003496) | 5.69792524 |
| 6 | Autoimmune thrombocytopenia (HP:0001973) | 5.62983122 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.57116410 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.94218850 |
| 9 | Basal ganglia calcification (HP:0002135) | 4.71732784 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 4.71233892 |
| 11 | Stomatitis (HP:0010280) | 4.36072785 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 4.30939180 |
| 13 | Recurrent skin infections (HP:0001581) | 4.29001132 |
| 14 | Vasculitis (HP:0002633) | 4.27455975 |
| 15 | Recurrent fungal infections (HP:0002841) | 4.01964462 |
| 16 | Myositis (HP:0100614) | 3.87334765 |
| 17 | Hypergammaglobulinemia (HP:0010702) | 3.87280861 |
| 18 | Orchitis (HP:0100796) | 3.82348439 |
| 19 | Gingivitis (HP:0000230) | 3.79548405 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 3.78945832 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.78945832 |
| 22 | Autoimmune hemolytic anemia (HP:0001890) | 3.75007901 |
| 23 | Porencephaly (HP:0002132) | 3.69414753 |
| 24 | Loss of speech (HP:0002371) | 3.64807673 |
| 25 | Interstitial pulmonary disease (HP:0006530) | 3.64566830 |
| 26 | Optic neuritis (HP:0100653) | 3.59666295 |
| 27 | Retrobulbar optic neuritis (HP:0100654) | 3.59666295 |
| 28 | Keratoconjunctivitis (HP:0001096) | 3.55411260 |
| 29 | Recurrent viral infections (HP:0004429) | 3.54006474 |
| 30 | Obstructive lung disease (HP:0006536) | 3.46628937 |
| 31 | Chronic obstructive pulmonary disease (HP:0006510) | 3.46628937 |
| 32 | Chronic otitis media (HP:0000389) | 3.43262975 |
| 33 | Vacuolated lymphocytes (HP:0001922) | 3.42799829 |
| 34 | Prostate neoplasm (HP:0100787) | 3.42232193 |
| 35 | Tetraparesis (HP:0002273) | 3.24479621 |
| 36 | Pustule (HP:0200039) | 3.17113684 |
| 37 | Peritonitis (HP:0002586) | 3.07552765 |
| 38 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.04862549 |
| 39 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.92757101 |
| 40 | Recurrent bronchitis (HP:0002837) | 2.92734906 |
| 41 | Thick nail (HP:0001805) | 2.91589800 |
| 42 | Periodontitis (HP:0000704) | 2.90867584 |
| 43 | Recurrent pneumonia (HP:0006532) | 2.89442299 |
| 44 | Increased cerebral lipofuscin (HP:0011813) | 2.85834886 |
| 45 | Poor head control (HP:0002421) | 2.84249254 |
| 46 | Pulmonary infiltrates (HP:0002113) | 2.83356825 |
| 47 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.78552102 |
| 48 | Urticaria (HP:0001025) | 2.73651448 |
| 49 | Recurrent lower respiratory tract infections (HP:0002783) | 2.70423960 |
| 50 | Axonal loss (HP:0003447) | 2.65658681 |
| 51 | Gingival bleeding (HP:0000225) | 2.64119314 |
| 52 | Petechiae (HP:0000967) | 2.63254318 |
| 53 | Dysostosis multiplex (HP:0000943) | 2.62326414 |
| 54 | Abnormality of T cell number (HP:0011839) | 2.62310338 |
| 55 | Encephalitis (HP:0002383) | 2.59897853 |
| 56 | Gangrene (HP:0100758) | 2.59896779 |
| 57 | Purpura (HP:0000979) | 2.58133903 |
| 58 | Abnormality of the endocardium (HP:0004306) | 2.56870960 |
| 59 | Cleft eyelid (HP:0000625) | 2.56384808 |
| 60 | Alveolar cell carcinoma (HP:0006519) | 2.56260650 |
| 61 | Leukocytosis (HP:0001974) | 2.56063138 |
| 62 | Amyloidosis (HP:0011034) | 2.55263494 |
| 63 | Joint swelling (HP:0001386) | 2.53051499 |
| 64 | Progressive neurologic deterioration (HP:0002344) | 2.52858285 |
| 65 | Gastrointestinal infarctions (HP:0005244) | 2.50233593 |
| 66 | Cellulitis (HP:0100658) | 2.49791242 |
| 67 | Hemoptysis (HP:0002105) | 2.49392020 |
| 68 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.47095102 |
| 69 | Prolonged neonatal jaundice (HP:0006579) | 2.45472198 |
| 70 | Nasal polyposis (HP:0100582) | 2.42656422 |
| 71 | Joint hemorrhage (HP:0005261) | 2.38131547 |
| 72 | Abnormality of T cell physiology (HP:0011840) | 2.36562409 |
| 73 | Abnormality of T cells (HP:0002843) | 2.35856287 |
| 74 | Premature loss of primary teeth (HP:0006323) | 2.35772455 |
| 75 | Meningitis (HP:0001287) | 2.34127186 |
| 76 | Hepatosplenomegaly (HP:0001433) | 2.33417365 |
| 77 | Increased serum ferritin (HP:0003281) | 2.33103644 |
| 78 | Chest pain (HP:0100749) | 2.32104216 |
| 79 | IgA deficiency (HP:0002720) | 2.31181352 |
| 80 | Abnormality of the nasal mucosa (HP:0000433) | 2.30415889 |
| 81 | Pulmonary embolism (HP:0002204) | 2.29142679 |
| 82 | Spontaneous hematomas (HP:0007420) | 2.28788893 |
| 83 | Myocardial infarction (HP:0001658) | 2.28354952 |
| 84 | Abnormality of the pericardium (HP:0001697) | 2.28109024 |
| 85 | Arterial thrombosis (HP:0004420) | 2.25369422 |
| 86 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.23419713 |
| 87 | Osteolytic defects of the hand bones (HP:0009699) | 2.23419713 |
| 88 | Episodic fever (HP:0001954) | 2.23376848 |
| 89 | Eosinophilia (HP:0001880) | 2.22995912 |
| 90 | IgG deficiency (HP:0004315) | 2.22178786 |
| 91 | Nephritis (HP:0000123) | 2.21970456 |
| 92 | Cheilitis (HP:0100825) | 2.17259410 |
| 93 | Anorexia (HP:0002039) | 2.17094708 |
| 94 | T lymphocytopenia (HP:0005403) | 2.16895961 |
| 95 | Disinhibition (HP:0000734) | 2.15193502 |
| 96 | Vertebral compression fractures (HP:0002953) | 2.14239975 |
| 97 | Osteomyelitis (HP:0002754) | 2.13113751 |
| 98 | Abnormality of the prostate (HP:0008775) | 2.12390494 |
| 99 | Bone pain (HP:0002653) | 2.12171280 |
| 100 | Glomerulonephritis (HP:0000099) | 2.11896943 |
| 101 | Increased IgE level (HP:0003212) | 2.11869085 |
| 102 | Progressive visual loss (HP:0000529) | 2.11019964 |
| 103 | Arthralgia (HP:0002829) | 2.09983894 |
| 104 | Hemorrhage of the eye (HP:0011885) | 2.09153777 |
| 105 | Abnormality of the basal ganglia (HP:0002134) | 2.08974671 |
| 106 | Abnormality of eosinophils (HP:0001879) | 2.07919478 |
| 107 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.07700520 |
| 108 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.07700520 |
| 109 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.07700520 |
| 110 | Lower limb hyperreflexia (HP:0002395) | 2.06583355 |
| 111 | Emphysema (HP:0002097) | 2.06483602 |
| 112 | Abnormality of iron homeostasis (HP:0011031) | 2.05768031 |
| 113 | Hematochezia (HP:0002573) | 2.05754587 |
| 114 | Vertigo (HP:0002321) | 2.05482080 |
| 115 | Glomerulopathy (HP:0100820) | 2.04059945 |
| 116 | Skin ulcer (HP:0200042) | 2.03169930 |
| 117 | Chronic sinusitis (HP:0011109) | 2.03067976 |
| 118 | Polyneuropathy (HP:0001271) | 2.02148165 |
| 119 | Abnormality of glycolipid metabolism (HP:0010969) | 2.01681100 |
| 120 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.01681100 |
| 121 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.01681100 |
| 122 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.01252131 |
| 123 | Parakeratosis (HP:0001036) | 2.00576285 |
| 124 | Chronic diarrhea (HP:0002028) | 1.99672193 |
| 125 | Neurofibrillary tangles (HP:0002185) | 1.99617113 |
| 126 | Mucopolysacchariduria (HP:0008155) | 1.98873632 |
| 127 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.98873632 |
| 128 | Keratoconjunctivitis sicca (HP:0001097) | 1.98468268 |
| 129 | Abnormality of the pleura (HP:0002103) | 1.96602302 |
| 130 | Keratitis (HP:0000491) | 1.96251705 |
| 131 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.95725323 |
| 132 | Apathy (HP:0000741) | 1.95188332 |
| 133 | Acne (HP:0001061) | 1.94753861 |
| 134 | Pigmentary retinal degeneration (HP:0001146) | 1.94228318 |
| 135 | Hypochromic microcytic anemia (HP:0004840) | 1.91692501 |
| 136 | Abnormality of the peritoneum (HP:0002585) | 1.89702987 |
| 137 | Diminished motivation (HP:0000745) | 1.86511904 |
| 138 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.83481053 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 5.14090029 |
| 2 | MAP3K14 | 4.49263710 |
| 3 | TBK1 | 4.20413290 |
| 4 | TYK2 | 3.99175201 |
| 5 | IKBKE | 3.97327007 |
| 6 | IRAK4 | 3.27477340 |
| 7 | BLK | 3.26970445 |
| 8 | JAK3 | 3.03718902 |
| 9 | RIPK4 | 2.99610449 |
| 10 | TXK | 2.75520768 |
| 11 | JAK1 | 2.72342798 |
| 12 | FGFR4 | 2.58522862 |
| 13 | IRAK3 | 2.37622237 |
| 14 | KIT | 2.35251372 |
| 15 | IKBKB | 2.33548493 |
| 16 | PIM2 | 2.28917153 |
| 17 | MAP3K13 | 2.03140853 |
| 18 | MAP2K3 | 1.91811262 |
| 19 | PRPF4B | 1.79016035 |
| 20 | MST4 | 1.75826029 |
| 21 | MAP3K3 | 1.75578803 |
| 22 | TAOK2 | 1.67616751 |
| 23 | MAP4K1 | 1.64149058 |
| 24 | CSK | 1.57123672 |
| 25 | BMPR2 | 1.55423914 |
| 26 | FGFR3 | 1.51442663 |
| 27 | ERN1 | 1.45745562 |
| 28 | TAOK1 | 1.40158904 |
| 29 | IRAK1 | 1.38924004 |
| 30 | CHUK | 1.36620907 |
| 31 | EPHA3 | 1.34005402 |
| 32 | ZAP70 | 1.33734666 |
| 33 | EIF2AK2 | 1.31695046 |
| 34 | MAP3K11 | 1.31678621 |
| 35 | EPHB1 | 1.26606953 |
| 36 | SYK | 1.24508784 |
| 37 | NEK9 | 1.21708436 |
| 38 | MATK | 1.17097349 |
| 39 | HCK | 1.15593566 |
| 40 | FGR | 1.07603667 |
| 41 | IRAK2 | 1.06326949 |
| 42 | MAP3K5 | 1.03943123 |
| 43 | BMX | 1.03147715 |
| 44 | LCK | 1.00571550 |
| 45 | RPS6KA4 | 0.98317184 |
| 46 | ABL2 | 0.97483872 |
| 47 | CDC42BPA | 0.96360248 |
| 48 | LYN | 0.94979941 |
| 49 | MST1R | 0.91251347 |
| 50 | TNK2 | 0.88932732 |
| 51 | JAK2 | 0.88374853 |
| 52 | STK4 | 0.87212668 |
| 53 | ARAF | 0.86026992 |
| 54 | PIM1 | 0.85342725 |
| 55 | NME2 | 0.78942116 |
| 56 | SIK3 | 0.77770642 |
| 57 | ADRBK2 | 0.77273951 |
| 58 | RIPK1 | 0.74614768 |
| 59 | ERBB3 | 0.71486757 |
| 60 | MARK3 | 0.70498841 |
| 61 | TAOK3 | 0.69542560 |
| 62 | TRPM7 | 0.69328451 |
| 63 | BTK | 0.67598229 |
| 64 | HIPK2 | 0.66565552 |
| 65 | STK24 | 0.66137456 |
| 66 | PRKCD | 0.66061631 |
| 67 | PRKD2 | 0.63719909 |
| 68 | TAF1 | 0.62020355 |
| 69 | GRK7 | 0.59234689 |
| 70 | ABL1 | 0.58822599 |
| 71 | MAP3K6 | 0.57793853 |
| 72 | MAP3K12 | 0.56959041 |
| 73 | TEC | 0.56156375 |
| 74 | EGFR | 0.52944029 |
| 75 | DAPK3 | 0.51130188 |
| 76 | MAPK7 | 0.50727838 |
| 77 | PRKCQ | 0.49477631 |
| 78 | PIK3CG | 0.48710095 |
| 79 | CSF1R | 0.47633530 |
| 80 | RPS6KA5 | 0.47507177 |
| 81 | TESK1 | 0.47407367 |
| 82 | BCR | 0.46298210 |
| 83 | SIK1 | 0.45175209 |
| 84 | NLK | 0.44890858 |
| 85 | TRIB3 | 0.42098397 |
| 86 | TGFBR2 | 0.41309298 |
| 87 | FES | 0.39242894 |
| 88 | STK3 | 0.39101083 |
| 89 | YES1 | 0.38124232 |
| 90 | MAP2K6 | 0.37446858 |
| 91 | KSR2 | 0.37169924 |
| 92 | ERBB4 | 0.35206017 |
| 93 | TTN | 0.34564434 |
| 94 | BMPR1B | 0.34472690 |
| 95 | KDR | 0.32561459 |
| 96 | SIK2 | 0.32554736 |
| 97 | MOS | 0.31817254 |
| 98 | GRK6 | 0.30549963 |
| 99 | DAPK2 | 0.28718448 |
| 100 | STK10 | 0.28378749 |
| 101 | MAP3K1 | 0.28209335 |
| 102 | MAPK11 | 0.27351375 |
| 103 | PDGFRA | 0.25588840 |
| 104 | FYN | 0.25383618 |
| 105 | MARK2 | 0.25351649 |
| 106 | TESK2 | 0.24648231 |
| 107 | LATS2 | 0.23281985 |
| 108 | PDGFRB | 0.22537820 |
| 109 | PRKCI | 0.22399131 |
| 110 | PKN1 | 0.22256946 |
| 111 | MELK | 0.21254217 |
| 112 | INSR | 0.21142098 |
| 113 | STK38 | 0.21015195 |
| 114 | IGF1R | 0.20093072 |
| 115 | SGK3 | 0.19752964 |
| 116 | NUAK1 | 0.19438986 |
| 117 | DYRK1B | 0.18505847 |
| 118 | MAPKAPK2 | 0.17719394 |
| 119 | PTK2B | 0.17591525 |
| 120 | PLK2 | 0.17513089 |
| 121 | CAMKK2 | 0.16768898 |
| 122 | ITK | 0.16651841 |
| 123 | SRC | 0.15765200 |
| 124 | PDK1 | 0.14360166 |
| 125 | PRKCE | 0.13575962 |
| 126 | DDR2 | 0.11539240 |
| 127 | CLK1 | 0.10757714 |
| 128 | PRKG2 | 0.10427098 |
| 129 | PDPK1 | 0.09757197 |
| 130 | CAMK1D | 0.08594201 |
| 131 | MAPK4 | 0.06716538 |
| 132 | RPS6KA1 | 0.04477610 |
| 133 | MAPK3 | 0.04246864 |
| 134 | PRKCH | 0.02741940 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.95575914 |
| 2 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.69483426 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.40679514 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.34881031 |
| 5 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 3.10841523 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 3.10315204 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.75937835 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.62997723 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.54863672 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.42612465 |
| 11 | Malaria_Homo sapiens_hsa05144 | 2.39906697 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.37719505 |
| 13 | Asthma_Homo sapiens_hsa05310 | 2.37105230 |
| 14 | Influenza A_Homo sapiens_hsa05164 | 2.32494327 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.31969320 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.31805115 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 2.29446740 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.26218391 |
| 19 | Pertussis_Homo sapiens_hsa05133 | 2.11229702 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.01546783 |
| 21 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.95566273 |
| 22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.95249026 |
| 23 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.93395008 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.92722493 |
| 25 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.81733074 |
| 26 | Salmonella infection_Homo sapiens_hsa05132 | 1.72849931 |
| 27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.66416158 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.50903122 |
| 29 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.50615325 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.42667635 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.39248959 |
| 32 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.35408267 |
| 33 | Phagosome_Homo sapiens_hsa04145 | 1.34501696 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.34408700 |
| 35 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.31731506 |
| 36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.31649420 |
| 37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.24951128 |
| 38 | * Hepatitis C_Homo sapiens_hsa05160 | 1.19001555 |
| 39 | Lysosome_Homo sapiens_hsa04142 | 1.17914062 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.14641427 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 1.11557808 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.01082974 |
| 43 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89108494 |
| 44 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88029630 |
| 45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86355969 |
| 46 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.85954561 |
| 47 | Amoebiasis_Homo sapiens_hsa05146 | 0.80975838 |
| 48 | Prion diseases_Homo sapiens_hsa05020 | 0.79764271 |
| 49 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.71060462 |
| 50 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.70146008 |
| 51 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.66331293 |
| 52 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.62507826 |
| 53 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61907205 |
| 54 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61830695 |
| 55 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.61581691 |
| 56 | Bladder cancer_Homo sapiens_hsa05219 | 0.59356641 |
| 57 | Proteasome_Homo sapiens_hsa03050 | 0.58813033 |
| 58 | Other glycan degradation_Homo sapiens_hsa00511 | 0.57601297 |
| 59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.57581613 |
| 60 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.53493691 |
| 61 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.53069134 |
| 62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50117097 |
| 63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47257802 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46356833 |
| 65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.45827689 |
| 66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.45079590 |
| 67 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.44414745 |
| 68 | Mineral absorption_Homo sapiens_hsa04978 | 0.43422252 |
| 69 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42634192 |
| 70 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.42145576 |
| 71 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41206089 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.35304433 |
| 73 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.33934794 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.32342168 |
| 75 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.31992624 |
| 76 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29690170 |
| 77 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.29503067 |
| 78 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.29132613 |
| 79 | Platelet activation_Homo sapiens_hsa04611 | 0.28345021 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.26432586 |
| 81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.25668341 |
| 82 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.25475126 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.24927819 |
| 84 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.24357301 |
| 85 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.23142934 |
| 86 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.21256819 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.21250817 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.20866768 |
| 89 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.20138196 |
| 90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.20100890 |
| 91 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.19644743 |
| 92 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.19608151 |
| 93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.19056319 |
| 94 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.18613479 |
| 95 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.17956635 |
| 96 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.17584518 |
| 97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.17009908 |
| 98 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.16159886 |
| 99 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.14235433 |
| 100 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.13202764 |
| 101 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.13123887 |
| 102 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.13022446 |
| 103 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.12883663 |
| 104 | HTLV-I infection_Homo sapiens_hsa05166 | 0.11604825 |
| 105 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.08421403 |
| 106 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.08204645 |
| 107 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.08025806 |
| 108 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.06267276 |
| 109 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.02606097 |
| 110 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.02333638 |
| 111 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.02330828 |
| 112 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.00102352 |
| 113 | Endocytosis_Homo sapiens_hsa04144 | -0.0071363 |
| 114 | ABC transporters_Homo sapiens_hsa02010 | -0.0059876 |
| 115 | MAPK signaling pathway_Homo sapiens_hsa04010 | -0.0055928 |

